"Located just northeast of Los Angeles, City of Hope's main campus bridges innovative science with compassionate patient care. Here, stretched across more than 100 acres in the City of Duarte, lushly landscaped gardens and open spaces surround our leading-edge medical, education and research facilities. City of Hope Duarte cares for patients from prevention through survivorship — using an array of world-class technologies, treatments and services and our expertise in cancers and conditions such as HIV and AIDS-related lymphoma."

During the past decade, City of Hope Medical Center conducted 282 clinical trials. In the 10-year time frame, 282 clinical trials started and 78 clinical trials were completed, i.e. on average, 27.7% percent of trials that started reached the finish line to date. In the past 5 years, 149 clinical trials started and 46 clinical trials were completed. i.e. 30.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "City of Hope Medical Center" #1 sponsor was "City of Hope Medical Center" with 328 trials, followed by "National Cancer Institute (NCI)" with 17 trials sponsored, "Children's Oncology Group" with 6 trials sponsored, "Fred Hutchinson Cancer Center" with 5 trials sponsored and "Merck Sharp & Dohme LLC" with 5 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "City of Hope Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 307 trials as a collaborator, "City of Hope Medical Center" with 5 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "National Institutes of Health (NIH)" with 4 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "City of Hope Medical Center" are "Breast Cancer" (18 trials), "Recurrent Mantle Cell Lymphoma" (16 trials), "Acute Myeloid Leukemia" (15 trials), "Hematopoietic and Lymphoid Cell Neoplasm" (15 trials) and "Myelodysplastic Syndrome" (14 trials). Many other conditions were trialed in "City of Hope Medical Center" in a lesser frequency.

Most popular intervention types in "City of Hope Medical Center" are "Drug" (254 trials), "Other" (247 trials), "Biological" (152 trials), "Procedure" (126 trials) and "Radiation" (45 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "laboratory biomarker analysis" (60 trials), "Questionnaire Administration" (59 trials), "Quality-of-Life Assessment" (50 trials) and "pharmacological study" (34 trials). Other intervention names were less common.

The vast majority of trials in "City of Hope Medical Center" are 359 trials for "All" genders, 46 trials for "Female" genders and 22 trials for "Male" genders.

Currently, there are 250 active trials in "City of Hope Medical Center". 4 are not yet recruiting, 121 are recruiting, 124 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 123 completed trials in City of Hope Medical Center, 2 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in City of Hope Medical Center, 176 "Phase 1" clinical trials were conducted, 147 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 86 trials that are defined as “Not Applicable".